top of page

BioSpace I OnQuality Pharma Raises $20 Million to Support Ongoing Oncodermatology Trial

By Gail Dutton OnQuality Pharmaceuticals just raised $20 million in Series A+ funding to support its Phase II oncodermatology trial. The trial assesses the safety and efficacy of a targeted supportive care agent that addresses the specific side effects of vascular endothelial growth factor receptor (VEGFR) inhibitors among cancer patients. Read more here:


bottom of page